Abstract: Four simple and sensitive ion-pairing spectrophotometric methods have been described for the assay of gemifloxacin mesylate (GFX) either in pure form or in pharmaceutical formulations. The developed methods involve formation of colored chloroform extractable ion-pair complexes of the drug with safranin O (SFN O) and methylene blue (MB) in basic medium; Napthol blue 12BR (NB 12BR) and azocaramine G (AG) in acidic medium. The extracted complexes showed absorbance maxima at 525, 650, 620 and 540 nm for SFN O, MB, NB 12BR and AG, respectively.Beer's law is obeyed in the concentration ranges 3-15, 4-20, 2-10 and 2-10 µg/mL with molar absorptivity of 2.81 x 10 4 , 2.20 x 10 4 , 4.02 x 10 4 and 4.15 x 10 4 L mole -1 cm -1 and relative standard deviation of 0.077, 0.104, 0.080 and 0.103% for SFN O, MB, NB 12BR and AG, respectively. These methods have been successfully applied for the assay of drug in pharmaceutical formulations. No interference was observed from common pharmaceutical adjuvants. Results of analysis were validated statistically and through recovery studies.
Introduction
Gemifloxacin, (R,S)-7-(3-aminomethyl-4-syn-methoxyimino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylicid methanesulfonate, is a new fluoroquinolone antibacterial compound with enhanced affinity for bacterial topoisomerase IV and is being developed for the treatment of respiratory and urinary tract infections. The compound has a broad spectrum of activity against Gram-positive and Gram-negative bacteria [1] [2] [3] . Literature survey revealed that few analytical methods have been reported for the estimation of GFX; they include high-performance liquid chromatography-tandem mass spectrometry (LC-MS-MS) [4] [5] , microchip electrophoresis 6 , chiral high-performance liquid chromatography 7 and chiral counter-current chromatography 8 . To the best of our knowledge, there is no work in the literature reported about the spectrophotometric method for the analysis of GFX in either biological fluids or pharmaceutical formulations. Hence the author has made an attempt to develop four simple and rapid spectrophotometric methods for the estimation of GFX in bulk drugs and in pharmaceutical formulations. The developed methods involve formation of colored chloroform extractable ion-pair complexes of the drug with safranin O and methylene blue in basic medium; napthol blue 12 BR and azocaramine G in acidic medium. The extracted complexes showed absorbance maxima at 525, 650, 620 and 540 nm for SFN O, MB, NB 12BR and AG, respectively.
Experimental

Apparatus
All spectral and absorbance measurements were made on a Systronic Model 117 digital spectrophotometer with 10mm matched quartz cells.
Materials and reagents
All chemicals used were of analytical reagent grade and double distilled water was used for preparing the reagent solutions. SFN O (0.2%) solution was prepared by dissolving 200 mg of safranin O in 100 mL of distilled water. MB (0.2%) solution was prepared by dissolving 200 mg of methylene blue in 100 mL of distilled water. Ammoniaammonium chloride buffer solution (pH 9.8) was prepared by mixing 7 g of ammonium chloride with 56.8 mL of liquor ammonia solution and diluted to 100 mL with distilled water and pH was adjusted to 9.8. NB 12 BR (0.2%) solution was prepared by dissolving 200 mg of napthol blue 12BR in 100 mL of distilled water. AG (0.05%) solution was prepared by dissolving 50 mg of azocaramine G in 100 mL of distilled water containing traces of sodium hydroxide.0.1 M HCl was prepared by diluting 8.6mL of concentrated hydrochloric acid to 1000 mL with distilled water and standardized. pH 1.5 buffer solution was prepared by mixing 289 mL of glycine solution (37.52 g of glycine and 29.24 g of NaCl were dissolved in 500 mL distilled water) with 711 mL of 0.1 M HCl and the pH of the solution was adjusted to 1.5.
Preparation of standard stock solutions
Stock solution of GFX was freshly prepared by dissolving 100mg of GFX in 100mL of distilled water and then this was further diluted with distilled water so as to obtain working standard solution of 60 µg/mL for SFN O, 80 µg/mL for MB, 40 µg/mL for NB 12BR and AG.
General procedures For SFN O and MB
Different aliquots of standard solution (60 µg/mL for SFN O and 80 µg/mL for MB) from 0.5-2.5mL and 1.0mL of pH 9.8 buffer solution were placed separately in a series of 125mL separating funnels. A volume of 1.5mL of SFN O or 0.5mL of MB was added respectively. The total volume in each funnel was adjusted to 10mL with distilled water. Then 10mL of chloroform was added to each separating funnel and the contents were shaken for 5 minutes and allowed to separate. The organic layer was collected through cotton plug and the absorbance was immediately measured at 525 nm for SFN O and at 650 nm for MB against the reagent blank. Both the colored species were stable for 1 hour. The calibration curves were constructed by plotting the absorbance versus final concentration of GFX. The amount of the drug was computed either from calibration curve or from regression equation.
For NB 12BR and AG
In to a series of 125 mL separating funnels containg aliquots of standard GFX solution (0.5-2.5 mL, 40 µg/mL), 6.0 mL of 0.1M HCl (for NB 12BR), or buffer solution pH 1.5 (AG) and 2.0 mL of dye solution were added. The total volume of aqueous phase in each separating funnel was adjusted to 15mL with distilled water and 10 mL of chloroform was added. The contents were shaken for 2 minutes and allowed to separate. The organic layer was collected through cotton plug and the absorbance was immediately measured at 620 nm for NB 12BR and at 540 nm for AG against the reagent blank. Both the colored species were stable for 1 hour. The calibration curves were constructed by plotting the absorbance versus final concentration of the GFX. The amount of the drug was computed either from calibration curve or from regression equation.
Procedure for the assay of the tablets
Twenty tablets were weighed accurately and ground in to a fine powder. An amount of powder equivalent to 50 mg of GFX was weighed into a 100 mL volumetric flask, about 20 mL of water containing 10 mL of the methanol were added and shaken thoroughly for about 20 min, then the volume was made up to the mark with the water, mixed well and filtered using a whatman filter paper #42 and the first few milliliters of the filtrate were discarded. The procedure was continued as mentioned under general procedures
Results and Discussion
GFX forms ion-pair complexes in basic buffer with dyestuffs such as SFN O and MB and these complexes are quantitatively extracted into chloroform. The ion-pair complexes with SFN O and MB absorbed maximally at 525 and 650 nm respectively. GFX also forms ionpair complexes in acidic medium with dyestuffs such as NB 12BR and AG and these complexes are quantitatively extracted into chloroform. The ion-pair complexes with NB 12BR and AG absorbed maximally at 620 and 540 nm respectively. Optimum conditions established for these methods were presented in Table 1 and 2.
The optical characteristics such as Beer's law limits, Sandell's sensitivity, molar absorptivity, percent relative standard deviation (calculated from eight replicate samples containing 3/4 th of the amount of the upper beer's law limits) were calculated for all the methods and the results are summarized in Table 3 . Regression characteristics like standard deviation of slope (S b ), standard deviation of intercept (S a ), standard error of estimation (S e ), % range of error (0.05 and 0.01 confidence limits) and detection limit were calculated for all the methods and are shown in Table 3 .
Commercial formulation of GFX was successfully analyzed by the proposed methods. The values obtained by the proposed methods are presented in Table 4 . The reliability of the proposed method was checked by standard addition method. The results (Table 5) show that the mean recoveries were found in the range 100.0-100.05 with RSD ≤0.55% for SFN O, 100.01-100.08 with RSD ≤0.54 for MB, 100.05-100.12 with RSD ≤0.61 for NB 12BR and 100.01-100.16 with RSD ≤0.57 for AG. Interference studies revealed that the common excipients and other additives usually present in dosage form did not interfere in the proposed methods. The performance order of the proposed methods is AG> NB 12BR > SFN O > MB. The other water immiscible solvents tested for the extraction of the colored complex into organic phase include chlorobenzene, dichloromethane, carbon tetrachloride, n-butanol and benzene. Chloroform was preferred for its selectivity extraction of the complex from the aqueous phase. Effect of the ratio of aqueous to organic phase on extraction 1:
The extraction of the colored species into chloroform layer was incomplete, where the ratio of aqueous to chloroform phase was more than the specified ratio in each case. The colored species after separation from organic layer was stable for 60 min, afterwards the absorbance gradually decreased. 
* Average of six independent analyses
In conclusion the proposed spectrophotometric methods for the estimation of GFX were simple, sensitive and accurate and can be used for the routine quality control of the drug in bulk as well as in pharmaceutical formulations.
